Box score
Synthesis Health Inc.
Reported $9.5M sold in a new Form D filed November 5, 2024 (Vancouver, outside the US).
- Biggest raise
- $9.5M filed Nov 5, 2024
- League
- Bio & Health Other Health Care
- Based in
- Vancouver, outside the US
- Season rank
- #373 of 1,389 in the Bio & Health League; #2076 of 12,443 overall (2024)
- Incorporated
- 2021
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-08-05 | Amendment | $23.8M | $25.5M | SEC |
| 2025-08-06 | New notice | $1.8M | $14.6M | SEC |
| 2024-11-05 | New notice | $9.5M | $14.4M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2040850.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Chemomab Therapeutics Ltd. | Bio & Health | $10M |
| 2 | RedHill Biopharma Ltd. | Bio & Health | $10M |
| 3 | Fertilidad Integral Ltd. | Bio & Health | $10M |
| 4 | NLS Pharmaceutics Ltd. | Bio & Health | $7.2M |
| 5 | Biodexa Pharmaceuticals Plc | Bio & Health | $6.8M |
| 6 | Entera Bio Ltd. | Bio & Health | $6.6M |